FDA

BMS Celebrates A New Day in Cancer Treatment with Approval of Opdualag
BioSpace
Sun, 03/20/22 - 11:09 pm
Bristol Myers Squibb
Opudualag
FDA
metastatic melanoma
Protalix eyes Fabry drug resubmission thanks to multiple phase 3 readouts
Fierce Biotech
Sun, 03/20/22 - 11:05 pm
Protalix BioTherapeutics
Fabry disease
FDA
clinical trials
PRX-102
Moderna seeks FDA authorization for a second booster dose of its coronavirus vaccine for all adults
Washington Post, DC
Fri, 03/18/22 - 10:57 am
Moderna Therapeutics
FDA
boosters
COVID-19
vaccines
What now for low-cost PD-(L)1 competition?
EP Vantage
Fri, 03/18/22 - 10:25 am
FDA
anti-PD-L1
Innovent
Eli Lilly
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months
Fierce Pharma
Thu, 03/17/22 - 11:33 pm
AbbVie
Rinvoq
ulcerative colitis
FDA
US replaces EU as priority market for medtech industry: survey
Medtech Dive
Thu, 03/17/22 - 10:26 am
FDA
devices
Medtech
Europe
Four Cancer Clinical Trials Advance with Blessing of FDA
BioSpace
Wed, 03/16/22 - 11:23 pm
cancer
oncology
FDA
clinical trials
Sonnet BioTherapeutics
SON-1010
solid tumors
Adagene
AD126
AIM ImmunoTech
Ampligen
pancreatic cancer
Wugen
WU-CART-007
Apellis plots pegcetacoplan FDA filing in blockbuster GA use after revealing 18-month data
Fierce Pharma
Wed, 03/16/22 - 10:37 am
Apellis
pegcetacoplan
geographic atrophy
FDA
FDA clears first generic of AZ’s blockbuster Symbicort
Pharmaforum
Wed, 03/16/22 - 10:21 am
Viatris
AstraZeneca
generics
FDA
Symbicort
Diabetes data put Better Therapeutics’ digital offering on track for FDA filing
MedCity News
Wed, 03/16/22 - 10:07 am
Better Therapeutics
digital health
digital pharma
Medtech
digital therapeutics
diabetes
FDA
Pfizer asks US to allow 4th COVID vaccine dose for seniors
AP
Tue, 03/15/22 - 11:30 pm
Pfizer
BioNTech
vaccines
FDA
COVID-19
boosters
FDA 'slow-walking' Novavax authorization: Expert
Motley Fool
Tue, 03/15/22 - 10:30 am
Novavax
vaccines
FDA
COVID-19
FDA orders Philips to notify customers about sleep device recall due to 'inadequate' prior efforts
Medtech Dive
Mon, 03/14/22 - 10:44 am
devices
Medtech
FDA
Philips
sleep apnea
product recalls
device recalls
FDA clears AstraZeneca, Merck drug to treat some genetic breast cancers early
BioPharma Dive
Mon, 03/14/22 - 10:26 am
AstraZeneca
Merck
Lynparza
genetic breast cancer
FDA
Immunome's COVID-19 antibody cocktail back on track for phase 1 after FDA lifts hold
Fierce Biotech
Fri, 03/11/22 - 11:01 am
Immunome
COVID-19
FDA
antibody cocktail
FDA panel to review once-rejected Acadia drug for psychosis
BioPharma Dive
Thu, 03/10/22 - 10:23 pm
Acadia Pharmaceuticals
FDA
Nuplazid
Alzheimer's disease psychosis
FDA reaches MDUFA V agreement with industry
Medtech Dive
Thu, 03/10/22 - 10:32 am
FDA
regulatory
devices
MDUFA
Medtech
Venatorx hits goal in antibiotic phase 3, clearing path to FDA
Fierce Biotech
Thu, 03/10/22 - 10:29 am
VenatoRx
antibiotics
clinical trials
FDA
UTIs
Pfizer will soon provide data to U.S. FDA on fourth COVID shot - Bloomberg
Seeking Alpha
Wed, 03/9/22 - 11:21 pm
Pfizer
vaccines
boosters
COVID-19
FDA
Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch
Fierce Biotech
Wed, 03/9/22 - 11:13 pm
Intellia Therapeutics
CRISPR
FDA
cell therapy
orphan drugs

Pages